Benzinga | Nov 12, 2021 05:40AM EST

Jefferies Upgrades GlycoMimetics to Buy, Raises Price Target to $4

Jefferies analyst Roger Song upgrades GlycoMimetics (NASDAQ:GLYC) from Hold to Buy and raises the price target from $3 to $4.